Impacts of a Statewide Prescription Drug Monitoring Program—Healthcare Practitioner Perspectives
{"This":[0,177],"study":[1,178],"examined":[2],"the":[3,20,54,223],"perceived":[4,80],"impacts":[5,81,95,139,151],"of":[6,22,38,98,140,206],"New":[7],"South":[8],"Wales'":[9],"(NSW)":[10],"statewide":[11],"prescription":[12,91],"drug":[13],"monitoring":[14],"program":[15],"(PDMP;":[16],"\\"SafeScript":[17],"NSW\\")":[18],"from":[19,130],"perspective":[21],"prescribers":[23,32,106],"and":[24,33,46,89,100,107,164,170,195,209,218,222],"pharmacists,":[25],"using":[26],"a":[27],"qualitative":[28],"descriptive":[29],"design.":[30],"Fourteen":[31],"pharmacists":[34,108],"who":[35,132],"were":[36,59,125,146,172],"users":[37,212],"NSW's":[39],"PDMP":[40,141,160],"completed":[41],"semi-structured":[42],"interviews":[43],"between":[44,122],"May":[45],"August":[47],"2024.":[48],"Thematic":[49],"analysis":[50],"was":[51],"guided":[52],"by":[53,175],"Quadruple":[55],"Aim":[56],"framework.":[57],"Impacts":[58,119],"classified":[60],"as":[61],"those":[62,131],"relating":[63,152],"to":[64,153,197],"(1)":[65],"population":[66,83],"health":[67,84],"outcomes,":[68],"(2)":[69],"patients'":[70],"care":[71],"experience,":[72],"(3)":[73],"costs,":[74],"(4)":[75],"practitioners'":[76,154,183],"work":[77],"experience.":[78],"PDMP's":[79],"on":[82,120,142,181,185],"included":[85,96],"improved":[86,110],"medication":[87],"safety":[88],"reduced":[90],"shopping.":[92],"Key":[93],"patient":[94],"risk":[97],"stigma":[99],"treatment":[101],"interruption.":[102],"Despite":[103],"these,":[104],"both":[105],"reported":[109,159],"therapeutic":[111],"relationships":[112,121],"with":[113,127,211],"patients":[114],"following":[115],"SafeScript":[116,136],"NSW":[117],"use.":[118],"healthcare":[123,143,182],"practitioners":[124],"mixed,":[126],"resistance":[128],"encountered":[129],"do":[133],"not":[134],"use":[135,161],"NSW.":[137],"No":[138],"delivery":[144],"costs":[145],"reported.":[147],"Participants":[148],"discussed":[149],"efficiency":[150],"work.":[155],"Both":[156],"practitioner":[157],"groups":[158],"increased":[162],"confidence":[163],"safer":[165],"prescribing/dispensing":[166],"practices.":[167],"Workflow":[168],"misalignment":[169],"workarounds":[171],"reported,":[173],"predominantly":[174],"pharmacists.":[176],"adds":[179],"evidence":[180],"perspectives":[184],"PDMP.":[186],"To":[187],"minimize":[188],"negative":[189],"impacts,":[190],"we":[191],"suggest":[192],"further":[193],"evaluation":[194],"strategies":[196,210],"address":[198],"user-identified":[199],"gaps,":[200],"including":[201],"workflow":[202],"challenges.":[203],"Collaborative":[204],"development":[205],"system":[207],"improvements":[208],"can":[213],"maximize":[214],"continued":[215],"user":[216],"acceptance":[217],"uptake,":[219],"benefits":[220],"realization,":[221],"system's":[224],"long-term":[225],"success.":[226]}
Authors
- Tracey‐Lea Laba (ORCID: https://orcid.org/0000-0002-5182-9092)
- Meredith Makeham (ORCID: https://orcid.org/0000-0001-7510-0901)
- Emma Tay (ORCID: https://orcid.org/0000-0003-1947-0267)
- Melissa Baysari (ORCID: https://orcid.org/0000-0003-1645-9126)
Institutions
- University of Technology Sydney (AU)
- The University of Sydney (AU)
- Sydney Local Health District (AU)
- South Western Sydney Local Health District (AU)
- Macquarie University (AU)
Publication Details
- Journal
- Pharmacology Research & Perspectives
- Published
- 2026-09-18
- DOI
- https://doi.org/10.1002/prp2.70326
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Avant Foundation